Phil Gutry - Dec 1, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
Christopher R. Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
4
Date filed
12/3/2021, 07:36 PM
Previous filing
Oct 4, 2021
Next filing
Feb 18, 2022

Phil Gutry is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

The reporting person resigned as a director of Avalo Therapeutics, Inc. effective December 1, 2021. As a result, the reporting person is no longer subject to Section 16 in connection with their transactions in the equity securities of Avalo Therapeutics, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.